VG Life Sciences (PK) Stock Price - VGLS

0.0059
0.0019 (47.5%)
0.0059
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
VG Life Sciences Inc (PK) VGLS OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0019 47.5% 0.0059 0.0059 0.0059 0.0059 0.004 16:25:56
Bid Price Ask Price Spread Spread % News
0.0025 0.0189 0.0164 86.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 204 $ 0.0059 $ 1 13,399 0.0017 - 0.0079
Last Trade Time Type Quantity Stock Price Currency
13:17:37 200 $ 0.0059 USD

VG Life Sciences (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 662.47k 112.28M 63.73M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
16.41k $ - 0.00% - -

more financials information »

VG Life Sciences (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VGLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0040.00590.0040.0042620.001947.5%
1 Month0.00380.00790.00380.004632435,5830.002155.26%
3 Months0.00690.00790.00370.00602538,951-0.001-14.49%
6 Months0.00320.00790.00320.005271850,6230.002784.38%
1 Year0.0040.00790.00170.004174576,2190.001947.5%
3 Years0.010.0190.00010.006574945,659-0.0041-41.0%
5 Years0.0720.090.00010.017664149,848-0.0661-91.81%

VG Life Sciences (PK) Description

About VG Life Sciences Inc.-- VG Life Sciences Inc., formerly known as Viral Genetics, Inc., is a biotechnology company focused on delivering treatments for patients suffering from autoimmune and chronic inflammatory disorders. Founded in 1995, the company controls over 40 US and international patents and pending patents, protecting its exclusive biotech platform technologies. The company is actively pursuing its custom-designed Targeted Peptide Technology for HIV/AIDS and is currently in per-clinical animal toxicity studies. The company is also nearing the completion of a Phase I P-IND study with its Metabolic Disruption Technology as a promising cancer combination therapy.


Your Recent History
USOTC
VGLS
VG Life Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.